Abortion


"KFF graphic with white text on a purple background that reads "Interactive Dashboard: Abortion in the United States." The graphic also has photo illustrations of the Supreme Court and abortion medication."

The Abortion in the United States Dashboard is an ongoing research project tracking state abortion policies and litigation following the overturning of Roe v. Wade. It features a continuously-updated map tracking the status of abortion bans across the United States, as well as briefs on topics such as medication abortion, insurance coverage, ballot measures, legal developments, and racial and ethnic disparities. It also offers a jumping off point to the latest national and state-specific abortion policies and statistics. Visit the Dashboard →


Filter

81 - 90 of 295 Results

  • A National Survey of OBGYNs’ Experiences After Dobbs

    Report

    This report, based on a nationally representative survey of office-based OBGYNs practicing in the United States, examines the provision of sexual and reproductive health care provided by OBGYNs before and after the Dobbs decision, comparing the experiences of OBGYNs practicing in states where abortion is fully banned, states with gestational restrictions, and states where abortion remains available under most circumstances.

  • Abortion Bans May Limit Essential Medications for Women with Chronic Conditions

    Issue Brief

    This analysis uses the 2019 IBM MarketScan claims data to look at prescriptions of methotrexate and misoprostol, two drugs that can be used to terminate pregnancies, but are also used to manage chronic conditions like cancer, autoimmune diseases, and abnormal bleeding. These drugs may be restricted in response to state abortion bans, which we find will disproportionately affect women of reproductive age who make up the majority of those who rely on these drugs.

  • Medicaid Coverage for Women

    Issue Brief

    This data note presents key data points describing the current state of the Medicaid program as it affects women.

  • Medication Abortion in a Post-Roe v. Wade America

    Event Date:
    Event

    On Wednesday, July 20th, a panel of experts joined series moderator Larry Levitt in a 45-minute discussion about the use and safety of medication abortion and the current and future policy and practical challenges for accessing it across the country.

  • What the Election Could Mean for the Mexico City Policy and U.S. Foreign Aid

    Issue Brief

    This analysis outlines the potential reach of a prominent conservative proposal — widely seen as a blueprint for another Trump administration — that recommends expanding the Mexico City Policy to include virtually all U.S. foreign assistance. It looks at the amount of funding, the number of organizations, the range of foreign assistance sectors, and other variables that could be affected should the proposal be implemented.

  • Louisiana v. FDA: Access to Mifepristone Back at the Supreme Court

    Issue Brief

    This brief reviews the case now before the Supreme Court, Louisiana v. FDA, and provides an overview of the other pending litigation involving mifepristone, and the mounting tension between states seeking to protect abortion and the states banning the provision of abortion.

  • Polling Insight: Republican Women Voters on Abortion

    Poll Finding

    This Polling Insight explores the abortion attitudes of Republican women voters leading up to the 2024 presidential election, including support for specific policies and their perceptions of the Republican Party on this issue.